Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 20, 2022 13:12 ET | Source: Nexalin Technology, Inc.

Nexalin Technology, Inc. Announces Closing of $9.6 Million Initial Public Offering

HOUSTON, TEXAS, Sept. 20, 2022 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the “Company” or “Nexalin”) today announced the closing of its previously announced initial public offering of 2,315,000...
September 19, 2022 17:00 ET | Source: Global Star Acquisition Inc.

Global Star Acquisition, Inc. Announces Pricing of $80,000,000 Initial Public Offering

MCLEAN, VA, Sept. 19, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Global Star Acquisition, Inc. (the “Company”) announced today that it priced its initial public offering of 8,000,000 units at...
September 19, 2022 16:10 ET | Source: Third Harmonic Bio

Third Harmonic Bio Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

CAMBRIDGE, Mass., Sept. 19, 2022 (GLOBE NEWSWIRE) -- Third Harmonic Bio, Inc. (Nasdaq: THRD), a clinical-stage biopharmaceutical company developing a potent, highly selective, oral KIT inhibitor for...
September 15, 2022 20:54 ET | Source: Nexalin Technology, Inc.

Nexalin Technology, Inc. Announces Pricing of $9.6 Million Initial Public Offering

HOUSTON, TEXAS, Sept. 15, 2022 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the “Company” or “Nexalin”) today announced the pricing of its initial public offering of 2,315,000 units consisting of...
September 15, 2022 16:50 ET | Source: CNB Financial

CNB Financial Corporation Announces Proposed Public Offering of $87 Million of its Common Stock

CLEARFIELD, Pa., Sept. 15, 2022 (GLOBE NEWSWIRE) -- CNB Financial Corporation (“CNB”) (NASDAQ: CCNE), the parent company of CNB Bank, announced today that it has commenced an underwritten public...
September 14, 2022 19:33 ET | Source: Third Harmonic Bio

Third Harmonic Bio Announces Pricing of Upsized Initial Public Offering

CAMBRIDGE, Mass., Sept. 14, 2022 (GLOBE NEWSWIRE) -- Third Harmonic Bio, Inc. (Nasdaq: THRD), a clinical-stage biopharmaceutical company developing a potent, highly selective, oral KIT inhibitor for...
September 13, 2022 13:03 ET | Source: EF Hutton Acquisition Corporation I

EF Hutton Acquisition Corporation I Announces Closing of Self-Underwritten $115,000,000 Initial Public Offering and Exercise of Full Over-Allotment Option

NEW YORK, NY, Sept. 13, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- EF Hutton Acquisition Corporation I (the "Company") today announced the closing of its initial public offering of 11,500,000...
September 12, 2022 21:05 ET | Source: Codiak BioSciences, Inc.

Codiak Announces Pricing of $20 Million Public Offering of Common Stock and Warrants

CAMBRIDGE, Mass., Sept. 12, 2022 (GLOBE NEWSWIRE) -- Codiak BioSciences, Inc. (Nasdaq: CDAK) (“Codiak”), a clinical-stage biopharmaceutical company pioneering the development of exosome-based...
September 08, 2022 17:00 ET | Source: EF Hutton Acquisition Corporation I

EF Hutton Acquisition Corporation I Announces Pricing of $100,000,000 Initial Public Offering

NEW YORK, NY, Sept. 08, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- EF Hutton Acquisition Corporation I (the "Company") announced today that it priced its initial public offering of 10,000,000...
September 01, 2022 08:30 ET | Source: Medigus Ltd

Medigus: Jeffs’ Brands Ltd. Announces Closing of $15.5 Million Initial Public Offering

As a result of the closing, Medigus now owns 35.27% of Jeffs' Brands Tel Aviv, Israel, Sept. 01, 2022 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced...